Second Sight Medical Products announced market entry into Russia, implanting the first patient with the company’s Argus II Retinal Prosthesis System in Moscow. The implant was facilitated by the country’s exclusive distribution partner, Medical Equipment Trading Company. The project was initiated by the Deaf-Blind Support Foundation Connection and supported by the Art, Science and Sport Charity Foundation and the Laboratory "Sensor-Tech" from Moscow.
“This first implant in Russia represents an important step as we seek to expand our global presence and make the Argus II available to more blind individuals worldwide. We are excited about the long-term potential of new markets, like Russia as well as our recent entry into South Korea and Taiwan,” Will McGuire, Chief Executive Officer of Second Sight, said in a company news release.
The first implant in Russia was performed at the Federal State Institution & Clinical Research Center of the Federal Medico-Biological Agency (FMBA) by a surgical team at the end of June 2017 in Moscow in a 59-year-old patient with retinitis pigmentosa. Dr. Paulo Stanga, Ophthalmologist & Vitreoretinal Surgeon at the Manchester Royal Eye Hospital, UK, proctored the surgery.